HB82 extends the technology readiness gross receipts tax credit from its current sunset date of July 1, 2027 to July 1, 2035. The credit is available to national laboratories operating in New Mexico that provide technology readiness assistance to qualifying businesses that are registered in the state and are either licensing technology from the lab or participating in a cooperative research and development agreement with the lab.
The bill keeps the basic structure of the existing credit but increases the annual aggregate cap per national laboratory in staged increments: $2 million for fiscal year 2027, $3 million for fiscal year 2028, $4 million for fiscal year 2029, and $5 million from fiscal year 2030 through fiscal year 2035. The per-business cap remains $150,000 per fiscal year, and unused credit may be carried forward. The bill also preserves application, reporting, coordination, and oversight requirements for national laboratories and the state agencies that administer the credit.
Impact
HB82 amends Section 7-9-96.3 NMSA 1978 and directly affects the Gross Receipts and Compensating Tax Act by extending and expanding a targeted gross receipts tax credit. It increases the potential tax benefit available to national laboratories for qualifying technology maturation assistance, while maintaining limits on eligible expenditures, business eligibility, and reporting obligations. The bill is intended to support commercialization of lab-developed technologies, encourage business growth in New Mexico, and promote economic development tied to national laboratory research.
Sentiment
The available context suggests generally favorable treatment of the bill, or at least no recorded opposition in the provided materials. There are no committee transcripts or recorded votes included, so sentiment must be inferred from the bill’s purpose and structure: it is framed as an economic development measure that continues an existing program rather than creating a new tax preference. The staged increase in the credit cap indicates support for expanding the program’s reach over time.
Contention
The main policy questions raised by the bill are fiscal and programmatic rather than ideological: whether extending the credit to 2035 and raising the annual caps is justified by the expected economic return, and whether the state should continue subsidizing national laboratory assistance through forgone gross receipts tax revenue. The bill addresses some potential concerns by requiring certifications from recipient businesses, coordination when multiple national laboratories assist the same business, annual reporting to state agencies and the legislature, and an economic impact study. No specific objections, amendments, or recorded dissent are included in the provided context.